Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Bérengère Debilly »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Bérangère Debilly < Bérengère Debilly < C Warren Olanow  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000170 (2011) Ingrid De Chazeron [France] ; Pierre-Michel Llorca [France] ; Isabelle Chéreau-Boudet [France] ; Olivier Blanc [France] ; Jean Perriot [France] ; Lemlih Ouchchane [France] ; Miguel Ulla [France] ; Bérengère Debilly [France] ; Philippe Derost [France] ; Franck Durif [France]Hypersexuality and pathological gambling in Parkinson's disease: A cross‐sectional case–control study
000206 (2010) Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France]Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study
000478 (2002) Franck Durif [France] ; Jean-Jacques Lemaire [France] ; Bérengère Debilly [France] ; Gérard Dordain [France]Long‐Term follow‐up of globus pallidus chronic stimulation in advanced Parkinson's disease

List of associated KwdEn.i

Nombre de
documents		Descripteur
3Humans
3Parkinson disease
3Parkinson's disease
2Aged
2Antiparkinson Agents (administration & dosage)
2Female
2Male
2Middle Aged
2Nervous system diseases
1Activities of Daily Living (classification)
1Activity
1Addiction
1Administration, Sublingual
1Adult
1Advanced stage
1Alcoholism (complications)
1Apomorphine (administration & dosage)
1Behavior, Addictive (complications)
1Case control study
1Case-Control Studies
1Combined Modality Therapy
1Cross sectional study
1Cross-Over Studies
1Cross-Sectional Studies
1Daily living
1Dominance, Cerebral (physiology)
1Dopamine agonist
1Dose-Response Relationship, Drug
1Double blind study
1Double-Blind Method
1Drug Administration Routes
1Drug of abuse
1Electric Stimulation Therapy
1Electrical stimulus
1Electrodes, Implanted
1Evolution
1Fluctuations
1Follow-Up Studies
1France
1Gambling (etiology)
1Globus Pallidus (physiopathology)
1Hypersexuality
1Instrumentation therapy
1Levodopa (administration & dosage)
1Logistic Models
1Long term
1Mental Status Schedule
1Motor Skills (physiology)
1Pallidum
1Parkinson Disease (complications)
1Parkinson Disease (diagnosis)
1Parkinson Disease (drug therapy)
1Parkinson Disease (physiopathology)
1Parkinson Disease (therapy)
1Pathological gambling
1Piribedil
1Piribedil (administration & dosage)
1Placebo
1Prognosis
1Proportional Hazards Models
1Quality of Life
1Retrospective Studies
1S90049
1Severity of Illness Index
1Sexual Dysfunctions, Psychological (etiology)
1Single dose
1addiction
1apomorphine
1chronic stimulation
1dopamine agonist
1globus pallidus
1motor fluctuations
1piribedil

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Bérengère Debilly" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Bérengère Debilly" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Bérengère Debilly
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024